Robert B Shapiro
CIK 1083227 · last filed 2023-03-13
Robert B Shapiro is a corporate insider who has filed 26 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider was granted $31.5K of PGEN on Mar 13, 2023. Across all open-market trades the lifetime net is +$529.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions. 24 SEC filings were submitted jointly with INTREXON CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
XON price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CHICAGO, IL 60610
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PGEN | Director | 412,622 | $6.36 | $2.62M | $0 | 8 | 2023-03-13 |
| PRECIGEN, INC. (XON) Delisted | Director | 150,471 | — | — | $529.9K | 15 | 2019-03-26 |
| NYSE Euronext (NYX) Delisted | Director | — | — | — | $0 | 1 | 2007-04-30 |
| DYADIC INTERNATIONAL INC (DIL) Delisted | Director | — | — | — | $0 | 1 | 2007-01-08 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-13 | PGEN | Grant (A) | +26,923 | $31.5K | EDGAR |
| 2023-02-24 | PGEN | Exer (M) | +61,576 | $0 | EDGAR |
| 2022-03-29 | PGEN | Exer (M) | +16,212 | $0 | EDGAR |
| 2022-02-24 | PGEN | Grant (A) | +31,034 | $63.0K | EDGAR |
| 2021-03-29 | PGEN | Grant (A) | +8,171 | $63.0K | EDGAR |
| 2021-03-16 | PGEN | Exer (M) | +62,189 | $0 | EDGAR |
| 2020-03-17 | PGEN | Grant (A) | +31,343 | $63.0K | EDGAR |
| 2020-03-10 | PGEN | Exer (M) | +24,703 | $0 | EDGAR |
| 2019-03-26 | PRECIGEN, INC. (XON) Delisted | Exer (M) | +7,911 | $0 | EDGAR |
| 2019-03-12 | PRECIGEN, INC. (XON) Delisted | Grant (A) | +12,450 | $63.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.